Abstract
Programmed Death Ligand 1 (PD-L1) positivity rates differ between different metastatic sites and the primary tumor. Understanding PD-L1 expression characteristics could guide biopsy procedures and motivate research to better understand...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have